Загрузка...
Should Restrictions Be Relaxed for Metformin Use in Chronic Kidney Disease? No, We Should Never Again Compromise Safety!
Metformin is and has been considered as first-line therapy for type 2 diabetes for over a quarter of a century. Like other biguanides, metformin can cause a lactic acidosis that is exceptionally rare but fatal. The likelihood of metformin-associated lactic acidosis is substantially higher in patient...
Сохранить в:
| Опубликовано в: : | Diabetes Care |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Diabetes Association
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4915554/ https://ncbi.nlm.nih.gov/pubmed/27330129 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc15-2327 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|